VistaGen Therapeutics (VTGN)

• Market cap: $24.9M
• 1 day: 4.08%
• 5 days: 13.51%
• 1 month: -2.89%
• 3 months: -2.71%
• 6 months: -84.5%
• Year to date: -7.56%
• 1 year: -70.25%
• 5 years: -98.96%
• 10 years: -99.49%
• Sector: Healthcare
• Industry: Biotechnology

About: Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

Employees: 59